Lightvision near-infrared fluorescence imaging system

Shimadzu Corp. has entered the medical near-infrared camera market with the release of the Lightvision near-infrared fluorescence imaging system. The new Lightvision is designed to support breast cancer treatment through the visualization of lymph vessels and blood vessels based on the detection of near-infrared fluorescent light emitted from indocyanine green (ICG).

The new Lightvision system creates real-time contrast images of lymph vessels below tissue surfaces by:

  • Administering ICG through the lymph vessels;

  • Exposing the corresponding tissue to excitation light; and

  • Then detecting and visualizing the slight emission of near-infrared light from the ICG, which is invisible to the naked eye.

By visualizing the lymph vessels during surgery, the surgeon can perform surgical procedures while monitoring the position of lymph vessels being excised, for example, on a monitor screen. This is especially useful for identifying the position of sentinel lymph nodes, which are important for diagnosing the metastasis status of cancer cells during breast cancer surgery.

Furthermore, by visualizing the ICG administered through blood veins, the blood flow can also be confirmed during surgery by performing intraoperative angiography. This is especially useful for evaluating blood flow through flaps and anastomotic vessels during breast reconstructive surgery.

Due to the high morbidity rate of breast cancer, compared to other cancers in women, there is an urgent need for countermeasures. However, diagnosing the metastasis of cancer cells during breast cancer surgery requires identifying the position of sentinel lymph nodes with a diameter of only a few millimeters and then excising those nodes to diagnose their pathology. If the cancer has not metastasized to the sentinel lymph node, then axillary lymph node excision can be omitted to prevent lymphedema and help maintain the patient's quality of life after surgery. For this reason, surgeons want to accurately determine the position of lymph nodes and quickly proceed with surgery.

In recent years, there has been increasing interest in using fluorescence methods with ICG for such sentinel lymph node biopsies. Due to Shimadzu's many years of experience involved in optical control and biological tissue fluorescence imaging technologies, it was thought that Shimadzu could apply those technologies for breast cancer surgery and other clinical fields by using them for medical diagnostic imaging. This resulted in the development of the LIGHTVISION near-infrared fluorescence imaging system.

Notable features on the system include:

1. Achieves High-Definition Image Quality

The Lightvision is equipped with built-in high-definition sensors, producing high-quality, real-time images on a single monitor, for surgeons to proceed with surgery. It also supports image acquisition in a bright field of view, without needing to switch off room lighting in the operating room.

2. Supports Simultaneous Display of Three Images

The ability to display three images simultaneously means that a visible light image, a near-infrared fluorescence image and a combined visible light image with superimposed near-infrared fluorescence image can all be displayed simultaneously, in real time, on the same monitor screen. This means that all three images can be assessed and compared with ease. To identify the position of lymph nodes, lymph vessels and blood vessels accurately in visible + near-infrared fluorescence images, areas of fluorescence can be displayed as either green or blue, providing clear visible separation from surrounding tissue.

3. Convenient Functionality and Operability Well-Suited to Use in Operating Rooms

The camera arm can be extended to a length of about 180 cm, providing optimal positioning during procedures, while the main unit is easily controlled via a simple and detachable control console. Excellent image quality is assured via automatic focusing, automatic light exposure adjustment and automatic white balance adjustment, while the images can be zoomed to a magnification of up to 10 times.

For more information: www.shimadzu.com


Related Content

News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | RSNA

Jan. 22, 2026 — The nomination deadline for the 2026 RSNA Rising Star Award is approaching. The Rising Star Award is ...

Time January 22, 2026
arrow
Subscribe Now